Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Genetic Variants in WNT2B and BTRC Predict Melanoma Survival.

Shi Q, Liu H, Han P, Li C, Wang Y, Wu W, Zhu D, Amos CI, Fang S, Lee JE, Han J, Wei Q.

J Invest Dermatol. 2017 Aug;137(8):1749-1756. doi: 10.1016/j.jid.2017.04.023. Epub 2017 May 10.

PMID:
28499756
2.

β-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma.

Yang CM, Ji S, Li Y, Fu LY, Jiang T, Meng FD.

Onco Targets Ther. 2017 Feb 20;10:711-724. doi: 10.2147/OTT.S117933. eCollection 2017.

3.

WNT/β-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner.

Brown K, Yang P, Salvador D, Kulikauskas R, Ruohola-Baker H, Robitaille AM, Chien AJ, Moon RT, Sherwood V.

Oncogene. 2017 Jun 1;36(22):3119-3136. doi: 10.1038/onc.2016.450. Epub 2017 Jan 16.

4.

Dual effects of collagenase-3 on melanoma: metastasis promotion and disruption of vasculogenic mimicry.

Zhao X, Sun B, Li Y, Liu Y, Zhang D, Wang X, Gu Q, Zhao J, Dong X, Liu Z, Che N.

Oncotarget. 2015 Apr 20;6(11):8890-9.

5.

Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.

Melbø-Jørgensen C, Ness N, Andersen S, Valkov A, Dønnem T, Al-Saad S, Kiselev Y, Berg T, Nordby Y, Bremnes RM, Busund LT, Richardsen E.

PLoS One. 2014 Nov 17;9(11):e113039. doi: 10.1371/journal.pone.0113039. eCollection 2014.

6.

Rad6 is a Potential Early Marker of Melanoma Development.

Rosner K, Adsule S, Haynes B, Kirou E, Kato I, Mehregan DR, Shekhar MP.

Transl Oncol. 2014 May 12. pii: S1936-5233(14)00044-8. doi: 10.1016/j.tranon.2014.04.009. [Epub ahead of print]

7.

Beta-catenin inhibits melanocyte migration but induces melanoma metastasis.

Gallagher SJ, Rambow F, Kumasaka M, Champeval D, Bellacosa A, Delmas V, Larue L.

Oncogene. 2013 Apr 25;32(17):2230-8. doi: 10.1038/onc.2012.229. Epub 2012 Jun 4.

8.

β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.

Damsky WE, Curley DP, Santhanakrishnan M, Rosenbaum LE, Platt JT, Gould Rothberg BE, Taketo MM, Dankort D, Rimm DL, McMahon M, Bosenberg M.

Cancer Cell. 2011 Dec 13;20(6):741-54. doi: 10.1016/j.ccr.2011.10.030.

9.

β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance.

Sinnberg T, Menzel M, Ewerth D, Sauer B, Schwarz M, Schaller M, Garbe C, Schittek B.

PLoS One. 2011;6(8):e23429. doi: 10.1371/journal.pone.0023429. Epub 2011 Aug 17.

10.

Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.

Gould Rothberg BE, Rimm DL.

J Invest Dermatol. 2010 Aug;130(8):1971-87. doi: 10.1038/jid.2010.149. Epub 2010 Jun 17.

11.

A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.

Frolova N, Edmonds MD, Bodenstine TM, Seitz R, Johnson MR, Feng R, Welch DR, Frost AR.

Tumour Biol. 2009;30(3):148-59. doi: 10.1159/000228908. Epub 2009 Jul 16. Erratum in: Tumour Biol. 2009;30(4):175.

12.

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

Gould Rothberg BE, Bracken MB, Rimm DL.

J Natl Cancer Inst. 2009 Apr 1;101(7):452-74. doi: 10.1093/jnci/djp038. Epub 2009 Mar 24. Review.

13.

Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications.

Halaban R, Krauthammer M, Pelizzola M, Cheng E, Kovacs D, Sznol M, Ariyan S, Narayan D, Bacchiocchi A, Molinaro A, Kluger Y, Deng M, Tran N, Zhang W, Picardo M, Enghild JJ.

PLoS One. 2009;4(2):e4563. doi: 10.1371/journal.pone.0004563. Epub 2009 Feb 23.

14.

Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma.

Kreizenbeck GM, Berger AJ, Subtil A, Rimm DL, Gould Rothberg BE.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):949-58. doi: 10.1158/1055-9965.EPI-07-2729.

15.

Understanding signaling cascades in melanoma.

Lopez-Bergami P, Fitchman B, Ronai Z.

Photochem Photobiol. 2008 Mar-Apr;84(2):289-306. Epub 2007 Dec 15. Review.

16.

Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics.

Chen W, Foran DJ.

Anal Chim Acta. 2006 Mar 30;564(1):74-81. Epub 2006 Jan 23.

18.

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

Alonso SR, Ortiz P, Pollán M, Pérez-Gómez B, Sánchez L, Acuña MJ, Pajares R, Martínez-Tello FJ, Hortelano CM, Piris MA, Rodríguez-Peralto JL.

Am J Pathol. 2004 Jan;164(1):193-203.

Supplemental Content

Support Center